AUA Guideline Update: Castration-Resistant Prostate Cancer Webcast
Course InformationAccess Materials Overview
This course will review the 2015 update to the 2013 AUA guidelines on castration-resistant prostate cancer. Faculty will explore the rigorous process used in the development of these evidence-based guidelines, as well as discuss new developments and future research needs for this topic. The course will showcase clinical scenarios in urological practice and the correct application of the new AUA guidelines in those instances. This course will be a benefit to practicing urologists, non-physician providers, residents preparing for their certification exam and physicians preparing for their re-certification exam.
After attending this course, participants will be able to:
- identify the active agents and their mechanism of action in the management of mCRPC
- analyze the evidence and outcomes on the treatment of CRPC as outlined in the AUA guidelines and subsequent amendments
- improve diagnostic and therapeutic decision making processes by illustrating the application of these guidelines in urological practice
- understand the sequencing and indications for active treatment with approved agents in the management of mCRPC
The AUA Office of Education would like to thank the companies who support continuing education of physicians. The AUA recognizes the following companies for providing educational grant support:
Bayer HealthCare Pharmaceuticals Inc.
Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC
Medivation, Inc., a Pfizer company
Tolmar Pharmaceuticals, Inc.
AUAER ensures that all educational activities are developed and implemented independent of the control and/or influence of any commercial interests (ACCME: SCS1)